Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 17 | 2026 | 1045 | 4.140 |
Why?
|
| Warm Ischemia | 4 | 2025 | 31 | 3.500 |
Why?
|
| Heart Transplantation | 7 | 2025 | 866 | 3.280 |
Why?
|
| Heart Failure | 17 | 2026 | 2289 | 3.050 |
Why?
|
| Oxidative Stress | 12 | 2018 | 756 | 2.890 |
Why?
|
| Organ Preservation | 4 | 2025 | 62 | 2.790 |
Why?
|
| Blood Platelets | 12 | 2018 | 312 | 2.690 |
Why?
|
| Air Pollution, Indoor | 9 | 2015 | 34 | 2.620 |
Why?
|
| Smoke | 8 | 2018 | 53 | 2.380 |
Why?
|
| Myocardium | 3 | 2025 | 847 | 1.990 |
Why?
|
| Brain Death | 3 | 2025 | 75 | 1.930 |
Why?
|
| Hemorrhage | 8 | 2019 | 492 | 1.840 |
Why?
|
| Cold Ischemia | 2 | 2025 | 28 | 1.830 |
Why?
|
| Mitochondria | 4 | 2024 | 730 | 1.630 |
Why?
|
| Cell Membrane | 2 | 2025 | 449 | 1.610 |
Why?
|
| Antigens, Nuclear | 4 | 2015 | 53 | 1.390 |
Why?
|
| Reactive Oxygen Species | 10 | 2018 | 493 | 1.300 |
Why?
|
| Tissue Donors | 4 | 2025 | 506 | 1.230 |
Why?
|
| Air Pollutants | 4 | 2013 | 109 | 1.210 |
Why?
|
| Pyroptosis | 2 | 2025 | 34 | 1.150 |
Why?
|
| Bronchi | 3 | 2015 | 102 | 1.060 |
Why?
|
| ADAM10 Protein | 1 | 2026 | 13 | 0.970 |
Why?
|
| Occupational Exposure | 2 | 2018 | 126 | 0.970 |
Why?
|
| Mouth Mucosa | 3 | 2011 | 46 | 0.960 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2026 | 62 | 0.950 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2026 | 68 | 0.940 |
Why?
|
| Organ Preservation Solutions | 1 | 2025 | 20 | 0.940 |
Why?
|
| Particulate Matter | 5 | 2015 | 75 | 0.940 |
Why?
|
| DNA Damage | 4 | 2013 | 498 | 0.930 |
Why?
|
| Biomass | 5 | 2015 | 25 | 0.900 |
Why?
|
| Cadherins | 1 | 2026 | 174 | 0.890 |
Why?
|
| Apoptosis | 3 | 2017 | 1811 | 0.880 |
Why?
|
| Respiratory Mucosa | 2 | 2018 | 96 | 0.850 |
Why?
|
| Delirium | 1 | 2025 | 66 | 0.850 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2015 | 200 | 0.830 |
Why?
|
| Antigens, CD | 1 | 2026 | 415 | 0.830 |
Why?
|
| Epithelial Cells | 7 | 2015 | 871 | 0.810 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 3 | 2018 | 43 | 0.790 |
Why?
|
| India | 10 | 2018 | 228 | 0.740 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 145 | 0.730 |
Why?
|
| Aged | 18 | 2026 | 20395 | 0.730 |
Why?
|
| Coronary Artery Bypass | 1 | 2026 | 525 | 0.730 |
Why?
|
| Platelet Activation | 6 | 2017 | 66 | 0.720 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2018 | 30 | 0.720 |
Why?
|
| Robotic Surgical Procedures | 1 | 2026 | 222 | 0.710 |
Why?
|
| Middle Aged | 20 | 2026 | 27758 | 0.710 |
Why?
|
| Sepsis | 1 | 2026 | 493 | 0.700 |
Why?
|
| Machine Learning | 1 | 2024 | 325 | 0.690 |
Why?
|
| Adult | 28 | 2026 | 30463 | 0.680 |
Why?
|
| Inhalant Abuse | 2 | 2011 | 3 | 0.680 |
Why?
|
| Brain | 2 | 2025 | 3039 | 0.650 |
Why?
|
| Environmental Exposure | 2 | 2013 | 212 | 0.650 |
Why?
|
| Membrane Proteins | 2 | 2026 | 1569 | 0.640 |
Why?
|
| Biofuels | 4 | 2013 | 10 | 0.630 |
Why?
|
| Female | 34 | 2026 | 68418 | 0.590 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 500 | 0.590 |
Why?
|
| Stroke | 2 | 2024 | 1027 | 0.580 |
Why?
|
| Curcumin | 1 | 2018 | 43 | 0.570 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2015 | 44 | 0.570 |
Why?
|
| DNA Repair | 2 | 2013 | 549 | 0.570 |
Why?
|
| Smoke Inhalation Injury | 1 | 2018 | 8 | 0.560 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2018 | 24 | 0.550 |
Why?
|
| Male | 26 | 2026 | 62623 | 0.540 |
Why?
|
| Humans | 44 | 2026 | 126923 | 0.540 |
Why?
|
| Integrins | 1 | 2017 | 88 | 0.530 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 101 | 0.520 |
Why?
|
| Postoperative Complications | 3 | 2026 | 3072 | 0.510 |
Why?
|
| Lung Transplantation | 1 | 2020 | 344 | 0.500 |
Why?
|
| Brain Ischemia | 1 | 2018 | 256 | 0.490 |
Why?
|
| Blood Platelet Disorders | 1 | 2015 | 15 | 0.460 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 799 | 0.450 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 219 | 0.450 |
Why?
|
| Cooking | 6 | 2013 | 36 | 0.450 |
Why?
|
| Neutrophils | 3 | 2012 | 350 | 0.440 |
Why?
|
| Leukocytes | 1 | 2015 | 203 | 0.430 |
Why?
|
| Biomarkers | 6 | 2026 | 3223 | 0.420 |
Why?
|
| Sulfur Dioxide | 1 | 2013 | 5 | 0.420 |
Why?
|
| Homeless Youth | 2 | 2011 | 11 | 0.410 |
Why?
|
| Nitrogen Dioxide | 1 | 2013 | 16 | 0.410 |
Why?
|
| Oxidative Phosphorylation | 2 | 2024 | 126 | 0.410 |
Why?
|
| Stress, Mechanical | 5 | 2015 | 169 | 0.380 |
Why?
|
| Inflammation | 5 | 2023 | 1425 | 0.380 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 278 | 0.360 |
Why?
|
| Soil | 2 | 2009 | 73 | 0.360 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2011 | 6 | 0.350 |
Why?
|
| Time Factors | 3 | 2025 | 6147 | 0.350 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 33 | 0.340 |
Why?
|
| Kidney | 4 | 2025 | 1283 | 0.330 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 59 | 0.330 |
Why?
|
| Adhesives | 1 | 2010 | 9 | 0.330 |
Why?
|
| Mouth | 1 | 2011 | 64 | 0.330 |
Why?
|
| Micronucleus Tests | 1 | 2010 | 3 | 0.330 |
Why?
|
| Fertilizers | 1 | 2009 | 4 | 0.310 |
Why?
|
| Thrombosis | 4 | 2019 | 503 | 0.310 |
Why?
|
| Brassica | 1 | 2009 | 16 | 0.310 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2309 | 0.310 |
Why?
|
| Superoxide Dismutase | 4 | 2015 | 170 | 0.300 |
Why?
|
| Nucleolus Organizer Region | 1 | 2009 | 3 | 0.300 |
Why?
|
| Lymphocytes | 1 | 2010 | 355 | 0.290 |
Why?
|
| Platelet Function Tests | 4 | 2015 | 39 | 0.280 |
Why?
|
| Heart | 2 | 2023 | 650 | 0.270 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 1493 | 0.270 |
Why?
|
| Triticum | 1 | 2007 | 28 | 0.260 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2025 | 16 | 0.240 |
Why?
|
| Lipoproteins, LDL | 2 | 2017 | 119 | 0.240 |
Why?
|
| Caspase 1 | 1 | 2025 | 45 | 0.240 |
Why?
|
| Procaine | 1 | 2025 | 12 | 0.240 |
Why?
|
| Disaccharides | 1 | 2025 | 19 | 0.240 |
Why?
|
| Mannitol | 1 | 2025 | 40 | 0.240 |
Why?
|
| Glutamates | 1 | 2025 | 58 | 0.230 |
Why?
|
| Electrolytes | 1 | 2025 | 57 | 0.230 |
Why?
|
| Histidine | 1 | 2025 | 73 | 0.230 |
Why?
|
| Coenzyme A Ligases | 1 | 2025 | 12 | 0.230 |
Why?
|
| Endostatins | 1 | 2025 | 9 | 0.230 |
Why?
|
| Preoperative Period | 1 | 2025 | 88 | 0.220 |
Why?
|
| Lipid Peroxidation | 1 | 2025 | 90 | 0.220 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 125 | 0.220 |
Why?
|
| Cystatin C | 1 | 2025 | 69 | 0.220 |
Why?
|
| Atrophy | 1 | 2025 | 238 | 0.220 |
Why?
|
| Glutathione | 1 | 2025 | 195 | 0.210 |
Why?
|
| Organ Size | 1 | 2025 | 429 | 0.210 |
Why?
|
| ROC Curve | 1 | 2026 | 587 | 0.210 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 2036 | 0.210 |
Why?
|
| Oxidoreductases | 1 | 2024 | 99 | 0.200 |
Why?
|
| NADPH Oxidases | 1 | 2024 | 108 | 0.200 |
Why?
|
| Death | 1 | 2024 | 76 | 0.200 |
Why?
|
| Flow Cytometry | 3 | 2015 | 754 | 0.200 |
Why?
|
| Edema | 1 | 2023 | 139 | 0.190 |
Why?
|
| Iron | 1 | 2025 | 298 | 0.180 |
Why?
|
| Fibrosis | 1 | 2023 | 400 | 0.180 |
Why?
|
| Neuroimaging | 1 | 2025 | 359 | 0.180 |
Why?
|
| Premenopause | 2 | 2012 | 36 | 0.180 |
Why?
|
| Blood-Brain Barrier | 2 | 2018 | 140 | 0.170 |
Why?
|
| Glucose | 1 | 2025 | 839 | 0.170 |
Why?
|
| Cheek | 2 | 2011 | 24 | 0.170 |
Why?
|
| von Willebrand Factor | 3 | 2017 | 184 | 0.160 |
Why?
|
| Perfusion | 1 | 2020 | 207 | 0.150 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2017 | 61 | 0.150 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2026 | 668 | 0.150 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2018 | 33 | 0.150 |
Why?
|
| Plant Shoots | 2 | 2009 | 7 | 0.140 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2018 | 5 | 0.140 |
Why?
|
| Plant Roots | 2 | 2009 | 30 | 0.140 |
Why?
|
| Plant Leaves | 2 | 2009 | 54 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2026 | 6232 | 0.140 |
Why?
|
| Shear Strength | 1 | 2017 | 15 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2010 | 551 | 0.140 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 108 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2025 | 664 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 122 | 0.130 |
Why?
|
| Hemostatics | 1 | 2017 | 58 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 83 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 275 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 2041 | 0.130 |
Why?
|
| Blood Coagulation | 2 | 2015 | 122 | 0.130 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 107 | 0.130 |
Why?
|
| Young Adult | 6 | 2018 | 9665 | 0.130 |
Why?
|
| Ethanol | 1 | 2018 | 159 | 0.130 |
Why?
|
| Platelet Aggregation | 4 | 2017 | 107 | 0.120 |
Why?
|
| Malondialdehyde | 1 | 2015 | 49 | 0.120 |
Why?
|
| Risk | 2 | 2015 | 730 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 783 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 424 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2015 | 237 | 0.110 |
Why?
|
| Particle Size | 2 | 2011 | 129 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 285 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17026 | 0.110 |
Why?
|
| Metaplasia | 1 | 2015 | 213 | 0.100 |
Why?
|
| Inhalation Exposure | 2 | 2011 | 34 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 308 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 143 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3319 | 0.100 |
Why?
|
| Sputum | 2 | 2011 | 116 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 257 | 0.100 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 85 | 0.100 |
Why?
|
| Lung | 1 | 2020 | 1517 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2015 | 211 | 0.100 |
Why?
|
| Logistic Models | 2 | 2015 | 1779 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 4511 | 0.100 |
Why?
|
| Neutrophil Activation | 1 | 2012 | 12 | 0.090 |
Why?
|
| Comet Assay | 1 | 2011 | 7 | 0.090 |
Why?
|
| Risk Factors | 4 | 2024 | 10573 | 0.090 |
Why?
|
| Natural Gas | 1 | 2011 | 5 | 0.090 |
Why?
|
| Hazardous Substances | 1 | 2011 | 17 | 0.090 |
Why?
|
| Rural Health | 1 | 2010 | 40 | 0.080 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 48 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 359 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2010 | 249 | 0.080 |
Why?
|
| Rural Population | 1 | 2011 | 246 | 0.080 |
Why?
|
| Seeds | 1 | 2009 | 41 | 0.080 |
Why?
|
| Energy-Generating Resources | 1 | 2009 | 1 | 0.080 |
Why?
|
| Silver Staining | 1 | 2009 | 5 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 781 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 477 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 286 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 423 | 0.070 |
Why?
|
| Chlorophyll | 1 | 2007 | 4 | 0.070 |
Why?
|
| Soil Microbiology | 1 | 2007 | 18 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 86 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2010 | 1536 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 2977 | 0.060 |
Why?
|
| Carotenoids | 1 | 2007 | 77 | 0.060 |
Why?
|
| P-Selectin | 2 | 2015 | 68 | 0.060 |
Why?
|
| Adolescent | 2 | 2011 | 20032 | 0.050 |
Why?
|
| Animals | 2 | 2018 | 33111 | 0.040 |
Why?
|
| Child | 3 | 2011 | 25121 | 0.040 |
Why?
|
| Acanthosis Nigricans | 1 | 2018 | 8 | 0.040 |
Why?
|
| Normal Distribution | 1 | 2018 | 19 | 0.040 |
Why?
|
| Hyperhomocysteinemia | 1 | 2018 | 37 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2018 | 70 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 247 | 0.030 |
Why?
|
| Homocysteine | 1 | 2018 | 118 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 148 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2017 | 154 | 0.030 |
Why?
|
| Exercise Test | 1 | 2018 | 243 | 0.030 |
Why?
|
| Propensity Score | 1 | 2017 | 250 | 0.030 |
Why?
|
| Collagen | 1 | 2017 | 292 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2018 | 172 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 950 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 452 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1539 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2015 | 27 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2018 | 494 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 460 | 0.030 |
Why?
|
| Heart, Artificial | 1 | 2015 | 63 | 0.030 |
Why?
|
| Monocytes | 1 | 2015 | 330 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 710 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 254 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2018 | 1311 | 0.020 |
Why?
|
| Receptors, Complement 3b | 1 | 2012 | 10 | 0.020 |
Why?
|
| CD18 Antigens | 1 | 2012 | 43 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 294 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2012 | 35 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 62 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2012 | 56 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 90 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2592 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2012 | 247 | 0.020 |
Why?
|
| Interleukins | 1 | 2012 | 119 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 481 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 578 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3664 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 637 | 0.020 |
Why?
|
| Antioxidants | 1 | 2011 | 321 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2012 | 461 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 873 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3262 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 12556 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7376 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 1986 | 83 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 3254 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1986 | 476 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6681 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 3909 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 17627 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 4478 | 0.010 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 1986 | 9 | 0.000 |
Why?
|